These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8528062)

  • 1. Expression of multidrug resistant gene (mdr-1/P-glycoprotein) in a megakaryoblastic cell line, CMK, and its enhancement during megakaryocytic differentiation.
    Sato T; Ota S; Kakuda H; Miura N; Niimi H; Ito M; Asai T; Tsuruo T; Fuse A
    Leuk Lymphoma; 1995 Aug; 18(5-6):515-20. PubMed ID: 8528062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of MDR-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells.
    Ota S; Sato T; Kakuda H; Hirano K; Okimoto Y; Mori T; Nakazawa S; Kojima S; Matsuyama T; Tsuruo T
    Leuk Lymphoma; 1995 Nov; 19(5-6):431-6. PubMed ID: 8590843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet factor 4 gene expression in a human megakaryocytic leukemia cell line (CMK) and its differentiated subclone (CMK11-5).
    Adachi M; Ryo R; Sato T; Yamaguchi N
    Exp Hematol; 1991 Oct; 19(9):923-7. PubMed ID: 1893970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of GM-CSF receptor beta-subunit and interleukin-6 receptor mRNA expression in a human megakaryocytic leukemia cell line.
    Yasunaga M; Ryo R; Yamaguchi N
    Leuk Lymphoma; 1992 Nov; 8(4-5):397-403. PubMed ID: 1290964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The involvement of the rho gene product, a small molecular weight GTP-binding protein, in polyploidization of a human megakaryocytic cell line, CMK.
    Takada M; Morii N; Kumagai S; Ryo R
    Exp Hematol; 1996 Mar; 24(4):524-30. PubMed ID: 8608802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
    Gu J; Fang X; Hao J; Sha X
    Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SON inhibits megakaryocytic differentiation via repressing RUNX1 and the megakaryocytic gene expression program in acute megakaryoblastic leukemia.
    Vukadin L; Kim JH; Park EY; Stone JK; Ungerleider N; Baddoo MC; Kong HK; Richard A; Tran J; Giannini H; Flemington EK; Lim SS; Ahn EE
    Cancer Gene Ther; 2021 Sep; 28(9):1000-1015. PubMed ID: 33247227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of granulysin mRNA in the human megakaryoblastic leukemia cell line CMK.
    Kitamura N; Koshiba M; Horie O; Ryo R
    Acta Haematol; 2002; 108(1):13-8. PubMed ID: 12145461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidrug resistance (Mdr1) gene expression in peripheral blasts from patients with acute leukemia only rarely increases during disease progression after combination chemotherapy.
    Gruber A; Areström I; Albertioni F; Björkholm M; Peterson C; Vitols S
    Leuk Lymphoma; 1995 Aug; 18(5-6):435-42. PubMed ID: 8528050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Megakaryocytic leukemia cell lines and megakaryocytic leukemia].
    Ryo R; Yoshida A; Yamaguchi N
    Rinsho Byori; 1990 May; 38(5):514-23. PubMed ID: 2381077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of smg p21/rap1A p21/krev-1 p21 gene expression during phorbol ester-induced differentiation of a human megakaryocytic leukemia cell line.
    Adachi M; Ryo R; Yoshida A; Sugano W; Yasunaga M; Saigo K; Yamaguchi N; Sato T; Sano K; Kaibuchi K
    Oncogene; 1992 Feb; 7(2):323-9. PubMed ID: 1549353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an anthracycline-resistant human promyelocyte leukemia (HL-60) cell line with an elevated MDR-1 gene expression.
    Jönsson K; Dahlberg N; Tidefelt U; Paul C; Andersson G
    Biochem Pharmacol; 1995 Mar; 49(6):755-62. PubMed ID: 7702633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug resistance-associated protein (MRP) in haematological malignancies.
    Nooter K; Burger H; Stoter G
    Leuk Lymphoma; 1996 Feb; 20(5-6):381-7. PubMed ID: 8833393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mdr-1 in refractory lymphoma: quantitation by polymerase chain reaction and validation of the assay.
    Kang YK; Zhan Z; Regis J; Alvarez M; Robey R; Meadows B; Dickstein B; Lee JS; Otsuki T; Stetler-Stevenson M
    Blood; 1995 Aug; 86(4):1515-24. PubMed ID: 7632959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blocking PAK1 kinase activity promotes the differentiation of acute megakaryocytic leukemia cells and induces their apoptosis].
    Wang SJ; Wang CQ; Hu XT; Yu XR; Fu CL
    Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):499-505. PubMed ID: 35968594
    [No Abstract]   [Full Text] [Related]  

  • 16. MDR-1 expression in non-Hodgkin's lymphomas is unrelated to treatment intensity or response to therapy.
    Finnegan MC; Royds J; Goepel JR; Lorigan P; Hancock BW; Goyns MH
    Leuk Lymphoma; 1995 Jul; 18(3-4):297-302. PubMed ID: 8535196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a human leukaemic cell line (CMK) with megakaryocytic characteristics from a Down's syndrome patient with acute megakaryoblastic leukaemia.
    Sato T; Fuse A; Eguchi M; Hayashi Y; Ryo R; Adachi M; Kishimoto Y; Teramura M; Mizoguchi H; Shima Y
    Br J Haematol; 1989 Jun; 72(2):184-90. PubMed ID: 2527057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance in leukemias and its reversal.
    Malayeri R; Filipits M; Suchomel RW; Zöchbauer S; Lechner K; Pirker R
    Leuk Lymphoma; 1996 Nov; 23(5-6):451-8. PubMed ID: 9031075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural analysis of a human megakaryocytic leukemia cell line (CMK11-5) in response to platelet agonists.
    Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Adachi M; Ryo R; Sato T
    Int J Hematol; 1993 Jan; 57(1):73-80. PubMed ID: 8477065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ribozyme-mediated reversal of the multidrug-resistant phenotype.
    Scanlon KJ; Ishida H; Kashani-Sabet M
    Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11123-7. PubMed ID: 7972021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.